Skip to main content
. 2020 Sep 21;11(11):3269–3279. doi: 10.1111/1759-7714.13667

Figure 4.

Figure 4

YTHDC2 predicts poor prognosis in lung cancer patients. (a, b) Overall survival and post progression survival analysis of all lung cancer patients from the Kaplan‐Meier Plotter database (Inline graphic) low (Inline graphic) high (Inline graphic) low (Inline graphic) high. (c, d) Overall survival analysis of LUAD and LUSC patients from the Kaplan‐Meier Plotter database (Inline graphic) low (Inline graphic) high (Inline graphic) low (Inline graphic) high.